Health, Subjective
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(2)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| surufatinib combined with camrelizumab | HUTCHMED (China) Limited (HCM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Health, Subjective?
BioSniper tracks 3 drugs in development for Health, Subjective across 1 company.
How many clinical trials target Health, Subjective?
There are 1 clinical trial targeting Health, Subjective tracked by BioSniper.
Analyze HUTCHMED (China) Limited's Health, Subjective pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company